TL1 Trainee Moses Chung shared the potential to conduct more accurate risk assessments and scalable decision support through a prognosis model examining the patient history of people with oropharyngeal squamous cell carcinoma (OPSCC).
TL1 Trainee Moses Chung Develops Approach to Improve the Prediction of Oropharyngeal Cancer Outcomes (Links to an external site)







